• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    LFW Photonics Market Index
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    Belite Bio, Inc - American Depositary Shares (NQ:BLTE)

    148.73 -1.10 (-0.73%)
    Streaming Delayed Price Updated: 4:00 PM EDT, Jun 26, 2026 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 255,725
    Open 150.17
    Bid (Size) 145.50 (500)
    Ask (Size) 149.69 (100)
    Prev. Close 149.83
    Today's Range 146.70 - 152.46
    52wk Range 56.10 - 200.00
    Shares Outstanding N/A
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    News headline image
    Belite Bio Completes Rolling Submission of New Drug Application to U.S. Food and Drug Administration for Tinlarebant for the Treatment of Stargardt Disease Type 1
    From Belite Bio, Inc
    Via GlobeNewswire
    News headline image
    Belite Bio to Participate in the Goldman Sachs 47th Annual Global Healthcare Conference
    From Belite Bio, Inc
    Via GlobeNewswire

    Performance

    YTD
    -6.6%
    -6.6%
    1 Month
    +0.5%
    +0.5%
    3 Month
    -0.3%
    -0.3%
    6 Month
    -10.0%
    -10.0%
    1 Year
    +151.9%
    +151.9%

    More News

    Read More
    News headline image
    Belite Bio Q1 Earnings Call Highlights ↗
    Via MarketBeat
    Topics Earnings
    Belite Bio Inc - ADR (NASDAQ:BLTE) Reports Narrower-Than-Expected Q4 Loss, NDA Submission on Track for 2026 ↗
    Via Chartmill
    News headline image
    Belite Bio (BLTE) Q1 2026 Earnings Transcript ↗
    Via The Motley Fool
    News headline image
    Belite Bio Reports Unaudited First Quarter 2026 Financial Results and Provides a Corporate Update
    From Belite Bio, Inc
    Via GlobeNewswire
    News headline image
    Belite Bio Receives Orphan Drug Status for Tinlarebant in Stargardt Disease in Switzerland
    From Belite Bio, Inc
    Via GlobeNewswire
    News headline image
    Belite Bio Announces Oral Presentation at the 27th Fundus Disease Forum and International Retinal Symposium (Retina China 2026)
    From Belite Bio, Inc
    Via GlobeNewswire
    News headline image
    Belite Bio to Host Webcast on May 20, 2026, to Discuss First Quarter 2026 Financial Results
    From Belite Bio, Inc
    Via GlobeNewswire
    News headline image
    Deutsche Bank ADR Virtual Investor Conference: Presentations Now Available for Online Viewing
    From Virtual Investor Conferences
    Via GlobeNewswire
    News headline image
    Belite Bio Announces Oral Presentation at the Retinal Therapeutics Innovation Summit
    From Belite Bio, Inc
    Via GlobeNewswire
    News headline image
    International companies to host live webcasts at Deutsche Bank’s Depositary Receipts Virtual Investor Conference on April 28, 2026
    From Virtual Investor Conferences
    Via GlobeNewswire
    News headline image
    Belite Bio to Participate in Four Upcoming Investor Conferences
    From Belite Bio, Inc
    Via GlobeNewswire
    News headline image
    Belite Bio to Present at the Deutsche Bank American Depositary Receipt Virtual Investor Conference on April 28th
    From Virtual Investor Conferences
    Via GlobeNewswire
    News headline image
    Belite Bio Initiates Rolling Submission of New Drug Application to the U.S. Food and Drug Administration for Tinlarebant for the Treatment of Stargardt Disease
    From Belite Bio, Inc
    Via GlobeNewswire
    News headline image
    Belite Bio Announces Availability of Annual Report on Form 20-F Through Company Website
    From Belite Bio, Inc
    Via GlobeNewswire
    News headline image
    Belite Bio (BLTE) Q4 2025 Earnings Call Transcript ↗
    Via The Motley Fool
    Topics Earnings
    News headline image
    Belite Bio to Participate in the Leerink Global Healthcare Conference
    From Belite Bio, Inc
    Via GlobeNewswire
    News headline image
    Belite Bio Reports Preliminary, Unaudited Fourth Quarter and Full Year 2025 Financial Results and Provides a Corporate Update
    From Belite Bio, Inc
    Via GlobeNewswire
    News headline image
    Belite Bio to Host Webcast on March 2, 2026, to Discuss Preliminary, Unaudited Fourth Quarter and Full Year 2025 Financial Results
    From Belite Bio, Inc
    Via GlobeNewswire
    News headline image
    Belite Bio Announces Participation at the 41st Asia-Pacific Academy of Ophthalmology Congress (APAO)
    From Belite Bio, Inc
    Via GlobeNewswire
    News headline image
    Belite Bio Completes Enrollment in the DRAGON II Clinical Trial of Tinlarebant for Stargardt Disease (STGD1)
    From Belite Bio, Inc
    Via GlobeNewswire
    InvestorNewsBreaks – Belite Bio, Inc (NASDAQ: BLTE) Prices $350M Underwritten Public Offering of ADSs
    Via Investor Brand Network
    News headline image
    Belite Bio Announces Pricing of $350.0 Million Underwritten Public Offering of American Depositary Shares
    From Belite Bio, Inc
    Via GlobeNewswire
    News headline image
    Why Belite Bio Stock Soared on Monday ↗
    Via The Motley Fool

    Frequently Asked Questions

    Is Belite Bio, Inc - American Depositary Shares publicly traded?
    Yes, Belite Bio, Inc - American Depositary Shares is publicly traded.
    What exchange does Belite Bio, Inc - American Depositary Shares trade on?
    Belite Bio, Inc - American Depositary Shares trades on the Nasdaq Stock Market
    What is the ticker symbol for Belite Bio, Inc - American Depositary Shares?
    The ticker symbol for Belite Bio, Inc - American Depositary Shares is BLTE on the Nasdaq Stock Market
    What is the current price of Belite Bio, Inc - American Depositary Shares?
    The current price of Belite Bio, Inc - American Depositary Shares is 148.73
    When was Belite Bio, Inc - American Depositary Shares last traded?
    The last trade of Belite Bio, Inc - American Depositary Shares was at 06/26/26 04:00 PM ET
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.